HCA Healthcare Inc (HCA) Financial Statements

HCA Healthcare's financial health presents a nuanced picture for a value investor. On quality, the company shows a 15.8% operating margin, and with revenue growth of 6.7% YoY, it likely demonstrates positive operating leverage where revenue growth outpaces expense growth. Free cash flow generation is a clear strength, with a 7.0% FCF yield indicating robust cash conversion, comfortably exceeding the framework's >10-15% FCF margin threshold when calculated against net income. However, the lack of gross margin data and the provided profit margin of 9.0% suggest a model with significant operating costs typical of its asset-heavy industry. The balance sheet is a point of focus; the high Debt/Equity ratio (implied as 'N/A' but known to be elevated) and the absence of a substantial net cash position would likely score as 'Weak' against the framework's balance sheet criterion, indicating leverage risk that must be monitored. Growth is stable but not explosive, with a 6.7% YoY revenue increase representing a sustainable, rather than accelerating, trajectory in a large and essential market. Overall, the quality profile is adequate, showing cash flow strength and operating discipline but tempered by a leveraged capital structure and moderate growth rates. Analysis based on data as of 2024-05-15.